Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Harvard Bioscience, Inc. (HBIO) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$21.77M |
|
$-50.34M |
|
$9.59M |
|
$12.18M |
|
$71.44M |
|
$-49.67M |
|
$-1.13M |
|
$-50.79M |
|
$-50.79M |
|
$-50.34M |
|
$-50.34M |
|
$-50.34M |
|
$-50.34M |
|
$-49.67M |
|
$0.07M |
|
44.10M |
|
44.10M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$44.90M |
|
$5.01M |
|
$34.90M |
|
$79.80M |
|
$55.60M |
|
-- |
|
$9.36M |
|
$64.97M |
|
$14.84M |
|
$-4.25M |
|
$14.84M |
|
44.21M |
|
| Cash Flow Statement Financials | |
$2.99M |
|
$-0.68M |
|
$-1.20M |
|
$4.11M |
|
$5.55M |
|
$1.44M |
|
$0.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.81 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
2.42 |
|
55.96% |
|
-228.11% |
|
-228.11% |
|
-- |
|
-233.28% |
|
-231.19% |
|
$2.47M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.42 |
|
1.62 |
|
55.71 |
|
-339.33% |
|
1183.08% |
|
-63.08% |
|
-339.33% |
|
$0.34 |
|
$0.06 |
|
$0.07 |
|